7730 Share Price Performance
JP¥1,887.00
778.00 (70.15%)
7.7% overvalued intrinsic discount
JP¥1,752.14
Fair Value
Price JP¥1,887.00
AnalystConsensusTarget JP¥1,752.14
AnalystLowTarget JP¥1,500.00
Fair ValueJP¥1,752.14
Share Pricen/a
Mani, Inc. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7730 Community Narratives
AN
Fair Value JP¥1.75k 7.7% overvalued intrinsic discount
7730: Fair Value And Marginal Shifts Will Guide Future Performance
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value JP¥1.5k 25.8% overvalued intrinsic discount
China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
Catalysts About Mani Mani manufactures and sells medical devices across Surgical, Eyeless Needle and Dental segments, with production and distribution spanning Japan, China, Europe, Vietnam and other regions. What are the underlying business or industry changes driving this perspective?Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
JP¥1.5k
25.8% overvalued intrinsic discount
Fair Value
Revenue
7.94% p.a.
Profit Margin
20.91%
Future PE
21.25x
Price in 2029
JP¥1.77k
7730: Fair Value And Marginal Shifts Will Guide Future Performance
Key Takeaways Return to growth in China and broadened global market reach are expected to boost revenue and enhance geographic diversification. Operational improvements and innovation are set to drive higher margins and capitalize on growing demand for premium healthcare devices.Read more
25
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
JP¥1.75k
7.7% overvalued intrinsic discount
Fair Value
Revenue
9.66% p.a.
Profit Margin
21.56%
Future PE
23.68x
Price in 2029
JP¥2.06k
Trending Discussion
Recently Updated Narratives
AN
China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
Fair Value: JP¥1.5k 25.8% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
7730: Dividend Guidance And Stable Assumptions Will Support Higher Future Upside
Fair Value: JP¥1.75k 7.7% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Mani, Inc. Key Details
Last Reported Earnings
Feb 28, 2026
Next Reporting Earnings
Jul 15, 2026
- 56.86
- 65.73%
- 17.92%
- 0%
About 7730
- Founded
- 1956
- Employees
- 4140
- CEO
- WebsiteView website
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
